Epsilon Imaging
RELATED CONTENT
Cardiac visualization and analysis software provider Epsilon Imaging announced the results of four studies presented at the ACC 2015 that demonstrated improved quality in assessment of heart function with EchoInsight visualization and analysis. These studies included:
March 26, 2015 
More than 55 companies displayed their latest products and services at the American Society of Echocardiography (ASE) 25th Annual Scientific Sessions June 20-24 in Portland, Ore. The meeting is the largest for cardiovascular ultrasound. Highlights from the show floor included:
July 03, 2014 
Epsilon Imaging Inc. has expanded its EchoInsight automated measurement suite for improved analysis and interpretation in echo.
April 07, 2014 
Epsilon Imaging Inc. has received the CE mark for its EchoInsight visualization and analysis platform with practical strain imaging for improved quality, standardization and workflow in echocardiography interpretation. The CE mark will allow EchoInsight to be sold in the European Union.
July 30, 2013 
Epsilon Imaging Inc. announced a clinical study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of left ventricle (LV) function. The study, presented at the ASE 2013 Scientific Sessions in Minneapolis, Minn., further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients.
July 10, 2013 
More than 54 companies will display their latest products and services at the American Society of Echocardiography’s (ASE) 24th Annual Scientific Sessions, planned for June 29-July 2 at the Minneapolis Convention Center in Minneapolis, Minn. This year, the conference theme is “a disease-based focus on the role of echocardiography in diagnosis and guiding therapy”.
June 25, 2013